Table 2. Site distribution.
Tumour | Maxilla |
Mandible |
||||||||||
A | P | M | U | A | P | M | PC | MC | MR | R | U | |
Ameloblastoma | 8 | 1 | 1 | 4 | 22 | 4 | 2 | 14 | 20 | 6 | 0 | 27 |
Keratocystic odontogenic tumour | 8 | 3 | 2 | 9 | 4 | 1 | 0 | 6 | 1 | 2 | 1 | 10 |
Adenomatoid odontogenic tumour | 7 | 4 | 0 | 4 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 4 |
Odontoma | 8 | 0 | 0 | 6 | 1 | 0 | 4 | 0 | 0 | 0 | 0 | 2 |
Odontogenic myxoma | 2 | 1 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 3 |
Odontogenic fibroma | 0 | 0 | 0 | 6 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5 |
Calcifying cystic odontogenic tumour | 1 | 5 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Ameloblastic fibroma, fibrodentinoma and fibro-odontoma | 0 | 1 | 1 | 1 | 0 | 1 | 2 | 0 | 3 | 1 | 0 | 1 |
Ameloblastic carcinoma | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
Calcifying epithelial odontogenic tumour | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Cementoblastoma | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
A, anterior region (incisors and canine); P, premolar region (premolar 1 and 2); M, molar region (Molar 1, 2 and 3); PC, premolar–canine region; MC, molar, premolar and canine; MR, molar and ramus; R, ramus; U, unknown